{"id":"https://openalex.org/W2394886376","doi":null,"title":"Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.","display_name":"Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.","alternate_titles":[],"publication_year":1988,"publication_date":"1988-03-01","ids":{"openalex":"https://openalex.org/W2394886376","mag":"2394886376","pmid":"https://pubmed.ncbi.nlm.nih.gov/3382459"},"language":"en","primary_location":{"id":"pmid:3382459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3382459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2394886376"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032450264","display_name":"Takahiro HIGASHIO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265712","display_name":"Ciba-Geigy Japan Limited (Japan)","ror":"https://ror.org/05h8ev729","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265712"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Higashio","raw_affiliation_strings":["Research and Development Subdivision, Ciba-Geigy Limited, Hyogo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Subdivision, Ciba-Geigy Limited, Hyogo, Japan","institution_ids":["https://openalex.org/I4405265712"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111365126","display_name":"Yasuhiko Tsuji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Tsuji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113627059","display_name":"Kazuki Nakao","orcid":"https://orcid.org/0009-0001-5407-0819","observed_orcids":["https://orcid.org/0009-0001-5407-0819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Nakao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S Sakaguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Sakaguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031619898","display_name":"Masaru Tanaka","orcid":"https://orcid.org/0000-0003-4383-4024","observed_orcids":["https://orcid.org/0000-0003-4383-4024"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Tanaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3529,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.59068934,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"3","first_page":"350","last_page":"358"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9101999998092651,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11700","display_name":"Hemodynamic Monitoring and Therapy","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cadralazine","display_name":"cadralazine","score":1.0},{"id":"https://openalex.org/keywords/vasodilators","display_name":"vasodilators","score":0.8640000224113464},{"id":"https://openalex.org/keywords/hydralazine","display_name":"hydralazine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hexamethonium","display_name":"hexamethonium","score":0.9909999966621399},{"id":"https://openalex.org/keywords/arterial-blood-pressure","display_name":"arterial blood pressure","score":0.6759999990463257},{"id":"https://openalex.org/keywords/systemic-vascular-resistance","display_name":"systemic vascular resistance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/renal-blood-flow","display_name":"renal blood flow","score":0.824999988079071},{"id":"https://openalex.org/keywords/femoral-blood-flow","display_name":"femoral blood flow","score":0.8370000123977661},{"id":"https://openalex.org/keywords/carotid-blood-flow","display_name":"carotid blood flow","score":0.8320000171661377},{"id":"https://openalex.org/keywords/superior-mesenteric-artery","display_name":"superior mesenteric artery","score":0.8289999961853027},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cardiac-output","display_name":"cardiac output","score":0.9890000224113464},{"id":"https://openalex.org/keywords/baroreflex","display_name":"baroreflex","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.5860000252723694},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C2775893369","wikidata":"https://www.wikidata.org/wiki/Q410557","display_name":"Hexamethonium","level":3,"score":0.9626789093017578},{"id":"https://openalex.org/C2780521442","wikidata":"https://www.wikidata.org/wiki/Q419987","display_name":"Hydralazine","level":3,"score":0.8392477035522461},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6422420740127563},{"id":"https://openalex.org/C58245268","wikidata":"https://www.wikidata.org/wiki/Q456026","display_name":"Vascular resistance","level":3,"score":0.6312980055809021},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6004375219345093},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.5518718361854553},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.5098444819450378},{"id":"https://openalex.org/C2779723990","wikidata":"https://www.wikidata.org/wiki/Q707174","display_name":"Femoral artery","level":2,"score":0.5064152479171753},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.49304625391960144},{"id":"https://openalex.org/C139940330","wikidata":"https://www.wikidata.org/wiki/Q596579","display_name":"Cardiac output","level":3,"score":0.47445163130760193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4701808989048004},{"id":"https://openalex.org/C79752029","wikidata":"https://www.wikidata.org/wiki/Q808732","display_name":"Baroreceptor","level":4,"score":0.42306971549987793},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3351982533931732},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000758","descriptor_name":"Anesthesia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002302","descriptor_name":"Cardiac Output","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005725","descriptor_name":"Ganglia, Autonomic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006584","descriptor_name":"Hexamethonium Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014655","descriptor_name":"Vascular Resistance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3382459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3382459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},{"id":"mag:2394886376","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3382459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2426628064","https://openalex.org/W2012575151","https://openalex.org/W2022677929","https://openalex.org/W2062550539","https://openalex.org/W1999300471","https://openalex.org/W2408358355","https://openalex.org/W1965090053","https://openalex.org/W2465720003","https://openalex.org/W2418887557","https://openalex.org/W2464287467"],"abstract_inverted_index":{"Hemodynamic":[0],"effects":[1],"of":[2,14,51,102,155,177,227,229,235],"the":[3,57,103,109,122,130,152,192,200,205,218,230],"newly":[4],"synthesized":[5],"vasodilator":[6],"cadralazine":[7,29,142],"(ethyl(+/)-6-[ethyl(2-hydroxypropyl)amino]-3-":[8],"pyridazinecarbazate)":[9],"were":[10,184],"compared":[11,71],"with":[12,72,136,202],"those":[13],"hydralazine":[15,73],"and":[16,21,31,38,43,56,63,75,93,127,159,169,181,186,216],"budralazine":[17,52],"in":[18,41,61,105,121,129,194,220,225],"hexamethonium":[19,26,137,167],"treated":[20],"non-treated":[22,27],"anesthetized":[23],"dogs.":[24],"In":[25],"dogs,":[28],"(1":[30],"3":[32],"mg/kg":[33,54,77],"i.v.)":[34,55],"exerted":[35],"a":[36,100,144,170],"dose-dependent":[37],"sustained":[39],"decrease":[40,104,146,153,172,219],"systolic":[42],"diastolic":[44],"arterial":[45,95,112,161],"blood":[46,96,139],"pressure":[47],"similar":[48],"to":[49,151,210],"that":[50,128],"(10":[53],"effect":[58,234],"was":[59,83,125,133,173,197],"slow":[60],"onset":[62],"long":[64],"lasting":[65],"until":[66],"5":[67],"h":[68],"after":[69],"administration":[70,176],"(0.5":[74],"1":[76],"i.v.).":[78],"Total":[79],"peripheral":[80],"vascular":[81,106,162,221],"resistance":[82,163,222],"decreased":[84,138,165],"by":[85,166,175,189,199,213],"these":[86],"three":[87],"drugs.":[88],"The":[89],"common":[90],"carotid,":[91],"femoral":[92,131,160],"renal":[94,123],"flow":[97,113,119],"increased":[98,188],"as":[99],"result":[101],"resistance,":[107],"but":[108,141,191],"superior":[110],"mesenteric":[111],"has":[114],"not":[115],"significantly":[116,187],"changed.":[117],"Blood":[118],"increase":[120],"artery":[124,132],"fast":[126],"predominant.":[134],"Treatment":[135],"pressure,":[140],"caused":[143,212],"further":[145,171],"within":[147],"60":[148],"min":[149],"similarly":[150],"pattern":[154],"hydralazine.":[156],"Common":[157],"carotid":[158],"also":[164],"treatment":[168,201],"observed":[174],"cadralazine.":[178,236],"Heart":[179],"rate":[180,196],"cardiac":[182],"output":[183],"immediately":[185],"cadralazine,":[190],"increment":[193],"heart":[195],"diminished":[198],"hexamethonium.":[203],"Therefore":[204],"tachycardiac":[206],"response":[207],"is":[208],"assumed":[209],"be":[211],"baroreceptor":[214],"reflex":[215],"compensates":[217],"which":[223],"results":[224],"moderation":[226],"manifestation":[228],"early":[231],"stage":[232],"hypotensive":[233]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2394886376","counts_by_year":[],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
